Outlook Therapeutics, Inc.OTLKNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-51.83T
↓ 900% below average
Average (9y)
$-5.18T
Historical baseline
Range
High:$-15.80M
Low:$-51.83T
CAGR
+369.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-51.83T | -75340109.9% |
| 2024 | $-68.79M | -60.1% |
| 2023 | $-42.97M | +24.2% |
| 2022 | $-56.67M | -4.5% |
| 2021 | $-54.25M | -70.7% |
| 2020 | $-31.79M | +2.9% |
| 2019 | $-32.73M | +8.6% |
| 2018 | $-35.82M | -126.8% |
| 2017 | $-15.80M | +66.1% |
| 2016 | $-46.58M | - |